Abstract:In recent years, the application of advanced analytics, especially artificial intelligence (AI), to digital H&E images, and other histological image types, has begun to radically change how histological images are used in the clinic. Alongside the recognition that the tumour microenvironment (TME) has a profound impact on tumour phenotype, the technical development of highly multiplexed immunofluorescence platforms has enhanced the biological complexity that can be captured in the TME with high precision. AI has an increasingly powerful role in the recognition and quantitation of image features and the association of such features with clinically important outcomes, as occurs in distinct stages in conventional machine learning. Deep-learning algorithms are able to elucidate TME patterns inherent in the input data with minimum levels of human intelligence and, hence, have the potential to achieve clinically relevant predictions and discovery of important TME features. Furthermore, the diverse repertoire of deep-learning algorithms able to interrogate TME patterns extends beyond convolutional neural networks to include attention-based models, graph neural networks, and multimodal models. To date, AI models have largely been evaluated retrospectively, outside the well-established rigour of prospective clinical trials, in part because traditional clinical trial methodology may not always be suitable for the assessment of AI technology. However, to enable digital pathology-based advanced analytics to meaningfully impact clinical care, specific measures of 'added benefit' to the current standard of care and validation in a prospective setting are important. This will need to be accompanied by adequate measures of explainability and interpretability. Despite such challenges, the combination of expanding datasets, increased computational power, and the possibility of integration of pre-clinical experimental insights into model development means there is exciting potential for the future progress of these AI applications. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Advances in the application of computational pathology in diagnosis, immunomicroenvironment recognition, and immunotherapy evaluation of breast cancer: a narrative review

Artificial intelligence's impact on breast cancer pathology: a literature review

Progress on deep learning in digital pathology of breast cancer: a narrative review

Recent Advances in Immunotherapy for Breast Cancer: A Review

A Systematic Review of Application Progress on Machine Learning-Based Natural Language Processing in Breast Cancer over the Past 5 Years

A review of machine learning approaches, challenges and prospects for computational tumor pathology

Applying artificial intelligence technology to assist with breast cancer diagnosis and prognosis prediction

Recent Advances in Diagnosis and Prognosis through Circulating Tumor Cells

Advancing personalized oncology: a systematic review on the integration of artificial intelligence in monitoring neoadjuvant treatment for breast cancer patients

Public health implications of computer-aided diagnosis and treatment technologies in breast cancer care

Computational pathology in cancer diagnosis, prognosis, and prediction – present day and prospects

Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer

Digital and Computational Pathology Applications in Bladder Cancer: Novel Tools Addressing Clinically Pressing Needs

Application of digital pathology-based advanced analytics of tumour microenvironment organisation to predict prognosis and therapeutic response

Artificial intelligence in digital histopathology for predicting patient prognosis and treatment efficacy in breast cancer

Artificial intelligence in cancer immunotherapy: Applications in neoantigen recognition, antibody design and immunotherapy response prediction

Evaluating Cancer-Related Biomarkers Based on Pathological Images: A Systematic Review

Advances in artificial intelligence to predict cancer immunotherapy efficacy

Immune Infiltrates in Breast Cancer: Recent Updates and Clinical Implications

Exploring different computational approaches for effective diagnosis of breast cancer

Emerging role of deep learning-based artificial intelligence in tumor pathology